VLX600 disrupts homologous recombination and synergizes with PARP inhibitors and cisplatin by inhibiting histone lysine demethylases

Thomas L. Ekstrom, Nicholas M. Pathoulas, Amelia M. Huehls, Arun Kanakkanthara, Larry M. Karnitz

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'VLX600 disrupts homologous recombination and synergizes with PARP inhibitors and cisplatin by inhibiting histone lysine demethylases'. Together they form a unique fingerprint.

Medicine & Life Sciences